Jamie Lopez Bernal

Best Publications

• Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

  Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher

  2593
  Citations

• Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

  James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson

  1374
  Citations

• Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.

  Unknown

  1226
  Citations

• Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.

  Anika Singanayagam;Monika Patel;Andre Charlett;Jamie Lopez Bernal

  968
  Citations

• COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

  Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  743
  Citations

• SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

  V J Hall;S Foulkes;A Charlett;A Atti

  690
  Citations

• Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.

  Simon de Lusignan;Simon de Lusignan;Jienchi Dorward;Jienchi Dorward;Ana Correa;Ana Correa;Nicholas Jones

  643
  Citations

• Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

  Unknown

  545
  Citations

• SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England.

  Sharif A Ismail;Sharif A Ismail;Vanessa Saliba;Jamie Lopez Bernal;Mary E Ramsay

  344
  Citations

• Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

  Jamie Lopez Bernal;Jamie Lopez Bernal;Jamie Lopez Bernal;Nick Andrews;Nick Andrews;Charlotte Gower;Eileen Gallagher

  342
  Citations

• Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack

  Jamie Lopez;Jamie Lopez;Olivia Susanto;Misty Jenkins;Misty Jenkins;Natalya Lukoyanova

  322
  Citations

• Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time

  Misty R. Jenkins;Jesse A. Rudd-Schmidt;Jamie A. Lopez;Jamie A. Lopez;Kelly M. Ramsbottom;Kelly M. Ramsbottom

  277
  Citations

• Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

  Unknown

  257
  Citations

• Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England

  Jamie Lopez Bernal;Jamie Lopez Bernal;Jamie Lopez Bernal;Nick Andrews;Nick Andrews;Charlotte Gower;Julia Stowe

  226
  Citations

• Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study

  Unknown

  223
  Citations

• Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design.

  Julia Stowe;Elise Tessier;Hongxin Zhao;Rebecca Guy

  194
  Citations

• Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

  Unknown

  192
  Citations

• Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

  Unknown

  191
  Citations

• Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.

  Madhumita Shrotri;Maria Krutikov;Tom Palmer;Rebecca Giddings

  179
  Citations

• COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England

  Unknown

  173
  Citations